3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Astrocytoma
8
Glioblastoma
5
Neuroectodermal Tumors, Primitive
3
Recurrence
2
Oligodendroglioma
2
Neurocytoma
2
Lymphoma, Non-Hodgkin
2
Glioma
2
Brain Neoplasms
2
Rhabdoid Tumor
1
Pancreatic Neoplasms
1
Neoplasms, Unknown Primary
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Meningioma
1
Melanoma
1
Lung Neoplasms
1
Gliosarcoma
1
Ganglioglioma
1
Esophageal Neoplasms
1
Ependymoma
1
Craniopharyngioma
1
Carcinoma, Non-Small-Cell Lung
1
Adrenocortical Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
etoposide phosphate
2
Radiotherapy
2
fluorodopa F 18
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Perfusion Magnetic Resonance Imaging
1
Microarray Analysis
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Immunologic Techniques
1
Immunohistochemistry
1
Ifosfamide
1
Etoposide
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Doxorubicin
1
Donepezil
1
Dasatinib
1
Cyproheptadine
1
Cilengitide
1
Carboplatin
1
Blotting, Western
1
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Optic Nerve Glioma
×
antineoplaston AS 2-1
×
Clear all
No trials found.